IDEAYA Biosciences Inc
F:30J
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
IDEAYA Biosciences Inc
F:30J
|
US |
|
A
|
Avenira Ltd
ASX:AEV
|
AU |
|
S
|
SSR Mining Inc
TSX:SSRM
|
CA |
|
Newcore Gold Ltd
F:PI8
|
CA |
|
N
|
Navakij Insurance PCL
SET:NKI
|
TH |
|
L
|
LivsMed Inc
KOSDAQ:491000
|
KR |
|
D
|
Ditto (Thailand) PCL
SET:DITTO
|
TH |
|
Mayora Indah Tbk PT
OTC:PTMYF
|
ID |
|
CB Financial Services Inc
F:M8M
|
US |
|
A
|
Azenta Inc
XMUN:BA3
|
US |
|
Molecure SA
F:1B1
|
PL |
|
Verbio SE
OTC:VBVBF
|
DE |
|
FlexQube AB (publ)
STO:FLEXQ
|
SE |
|
DTS Corp
F:DA9
|
JP |
|
A
|
AGFA Gevaert NV
SWB:AGE
|
BE |
|
O
|
OBI Pharma Inc
TPEX:4174
|
TW |
|
Lippo Karawaci Tbk PT
OTC:PTLKF
|
ID |
|
P
|
PJ Electronics Co Ltd
KOSDAQ:006140
|
KR |
|
E
|
EPIC Suisse AG
SIX:EPIC
|
CH |
|
U
|
UTG Inc
OTC:UTGN
|
US |
|
E
|
Egide SA
SWB:EGID
|
FR |
|
Victory Capital Holdings Inc
NASDAQ:VCTR
|
US |
|
Stadler Rail AG
F:6RL
|
CH |
|
B
|
Bridgemarq Real Estate Services Inc
F:BG8
|
CA |
Bankruptcy Probability
IDEAYA Biosciences Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
IDEAYA Biosciences Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
IDEAYA Biosciences Inc
NASDAQ:IDYA
|
3.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
479.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
223.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
182.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
128.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
78.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
76.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
86.9B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
56.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
44.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
43B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
IDEAYA Biosciences Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, IDEAYA Biosciences Inc has no debt.
You can find a full breakdown on its Balance Sheet.